Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
about
Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure.Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital.
P2860
Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Proton pump inhibitors and his ...... herapeutic and adverse events.
@en
type
label
Proton pump inhibitors and his ...... herapeutic and adverse events.
@en
prefLabel
Proton pump inhibitors and his ...... herapeutic and adverse events.
@en
P2093
P2860
P1476
Proton pump inhibitors and his ...... therapeutic and adverse events
@en
P2093
Douglas N Fish
Lynn E Kassel
Robert MacLaren
P2860
P304
P356
10.1517/14740338.2015.986456
P407
P577
2014-11-25T00:00:00Z